Clinical Trials Logo

Clinical Trial Summary

To compare efficacy and safety of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.


Clinical Trial Description

Prasugrel and ticagrelor are recommended in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Both prasugrel and ticagrelor show more rapid and potent antiplatelet effect compared with clopidogrel. However, previous report comparing the efficacy and safety of prasugrel and ticagrelor in patients with STEMI of East Asian ethnicity is lacking. Therefore, the aim of this study is to compare the antiplatelet efficacy and safety using laboratory platelet function tests and clinical outcomes in patients with STEMI treated with either prasugrel or ticagrelor. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02075125
Study type Interventional
Source Dong-A University
Contact
Status Terminated
Phase Phase 3
Start date January 2014
Completion date April 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05669222 - The FAVOR V AMI Trial N/A
Recruiting NCT02894138 - Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study Phase 3
Completed NCT02641262 - Henan STEMI Registry
Completed NCT01826552 - Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent Phase 4
Recruiting NCT01738100 - Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention Phase 2
Completed NCT05895123 - Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients Phase 2
Completed NCT03671603 - Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
Recruiting NCT02606435 - Thrombus Aspiration in Patients With STEMI Phase 4
Completed NCT01203982 - Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT) Phase 4
Active, not recruiting NCT03338309 - INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
Recruiting NCT02445885 - Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction N/A
Not yet recruiting NCT04984915 - The Usefulness of CaIMR in Patients With STEMI
Active, not recruiting NCT03371784 - The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER) Phase 2/Phase 3
Completed NCT03389503 - Comparison of Left and Right Transradial Approach for CAG and PCI N/A
Completed NCT02311231 - Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART Phase 4
Completed NCT02324348 - Efficacy and Safety Study of Deferred Stenting in Patients With STEMI N/A
Completed NCT01385631 - Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction. Phase 4
Completed NCT03690713 - International Collaboration of Comprehensive Physiologic Assessment
Enrolling by invitation NCT02670005 - Fractional Flow Reserve Versus Angiography for Guiding Selective Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction N/A
Completed NCT02164695 - Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction N/A